Efficacy and Safety of Ceritinib in Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC): An Update of ASCEND-1
暂无分享,去创建一个
Michael Thomas | A. Shaw | Gregory Riely | E. Felip | B. Solomon | A. Santoro | R. Mehra | D. Camidge | D. Tan | L. Chow | J. Vansteenkiste | J. Wolf | M. Schuler | Geoffrey Liu | Sanjay Sharma | M. Geraldes | D. Kim | A. Yovine | T. Pas | Anthony Boral